Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Chebib

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 10, 2017
The Synthesis and Evaluation of Fluoro-, Trifluoromethyl-, and Iodomuscimols as GABA AgonistsMohd Abdul Fatah Abdul Manan, David B Cordes, Alexandra M Z Slawin, et al.
Brain Sciences|April 3, 2021
Targeting GABA<sub>C</sub> Receptors Improves Post-Stroke Motor RecoveryPetra S van Nieuwenhuijzen, Kim Parker, Vivian Liao, et al.
Future Medicinal Chemistry|March 25, 2011
Medicinal chemistry of ρ GABAC receptorsClarissa K L Ng, Hye-lim Kim, Navnath Gavande, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2012
Consequences of linker length alteration of the α7 nicotinic acetylcholine receptor (nAChR) agonist, SEN12333Corinne Beinat, Samuel D Banister, Saundra van Prehn, et al.
Bioorganic & Medicinal Chemistry|September 29, 2009
Synthesis and biological evaluation of flavan-3-ol derivatives as positive modulators of GABAA receptorsKenneth N Mewett, Sebastian P Fernandez, Anmol K Pasricha, et al.
British Journal of Pharmacology|April 19, 2018
Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptorsNatalia M Kowal, Philip K Ahring, Vivian W Y Liao, et al.
Epilepsia|October 19, 2019
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactionsLyndsey L Anderson, Nathan L Absalom, Sarah V Abelev, et al.
Neurochemical Research|April 24, 2009
Guanidino acids act as rho1 GABA(C) receptor antagonistsMary Chebib, Navnath Gavande, Kit Yee Wong, et al.
Biochemical Pharmacology|June 5, 2012
Low nanomolar GABA effects at extrasynaptic α4β1/β3δ GABA(A) receptor subtypes indicate a different binding mode for GABA at these receptorsNasiara Karim, Petrine Wellendorph, Nathan Absalom, et al.
The Journal of Biological Chemistry|July 30, 2013
Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4β2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealedNathan L Absalom, Gracia Quek, Trevor M Lewis, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 10, 2017
The Synthesis and Evaluation of Fluoro-, Trifluoromethyl-, and Iodomuscimols as GABA AgonistsMohd Abdul Fatah Abdul Manan, David B Cordes, Alexandra M Z Slawin, et al.
Brain Sciences|April 3, 2021
Targeting GABA<sub>C</sub> Receptors Improves Post-Stroke Motor RecoveryPetra S van Nieuwenhuijzen, Kim Parker, Vivian Liao, et al.
Future Medicinal Chemistry|March 25, 2011
Medicinal chemistry of ρ GABAC receptorsClarissa K L Ng, Hye-lim Kim, Navnath Gavande, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2012
Consequences of linker length alteration of the α7 nicotinic acetylcholine receptor (nAChR) agonist, SEN12333Corinne Beinat, Samuel D Banister, Saundra van Prehn, et al.
Bioorganic & Medicinal Chemistry|September 29, 2009
Synthesis and biological evaluation of flavan-3-ol derivatives as positive modulators of GABAA receptorsKenneth N Mewett, Sebastian P Fernandez, Anmol K Pasricha, et al.
British Journal of Pharmacology|April 19, 2018
Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptorsNatalia M Kowal, Philip K Ahring, Vivian W Y Liao, et al.
Epilepsia|October 19, 2019
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactionsLyndsey L Anderson, Nathan L Absalom, Sarah V Abelev, et al.
Neurochemical Research|April 24, 2009
Guanidino acids act as rho1 GABA(C) receptor antagonistsMary Chebib, Navnath Gavande, Kit Yee Wong, et al.
Biochemical Pharmacology|June 5, 2012
Low nanomolar GABA effects at extrasynaptic α4β1/β3δ GABA(A) receptor subtypes indicate a different binding mode for GABA at these receptorsNasiara Karim, Petrine Wellendorph, Nathan Absalom, et al.
The Journal of Biological Chemistry|July 30, 2013
Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4β2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealedNathan L Absalom, Gracia Quek, Trevor M Lewis, et al.
Pageof 13